Search results
‘AI Craze’ Powers Best Week in 2024 for Stocks: Markets Wrap
Bloomberg via Yahoo Finance· 3 days ago(Bloomberg) -- A rally in the world’s largest technology companies lifted stocks, with Wall Street...
Dividend Growth Stars: 7 Stocks With 10-Year Double-Digit Rate Hikes
InvestorPlace· 6 days agoBecause dividend investing has such an impressive track record of beating non-dividend-paying...
Dividend Growth Stars: 7 Stocks With 10-Year Double-Digit Rate Hikes
InvestorPlace via Yahoo Finance· 6 days agoBecause dividend investing has such an impressive track record of beating non-dividend-paying...
Eli Lilly (LLY) Reports Next Week: Wall Street Expects Earnings Growth
Zacks· 7 days agoThis widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the ...
News Highlights: Top Company News of the Day - Friday at 5 PM ET
Morningstar· 3 days agoThe board is considering installing a committee of top executives to run the company on an interim basis as turmoil over sale talks deepens. The oil companies are still printing big profits, ...
12 Under-the-Radar High Dividend Stocks to Invest in Now
Insider Monkey via Yahoo Finance· 2 days agoIn this article, we discuss 12 under-the-radar high dividend stocks to invest in now. You can skip...
Cigna to offer Humira rivals with $0 copay at specialty pharmacy
Reuters· 4 days agoCigna plans to make close copies of AbbVie's blockbuster arthritis drug Humira available with no...
Here’s why ImmunityBio (IBRX) stock price surged and what next | Invezz
Invezz· 7 days agoImmunityBio (NASDAQ: IBRX) stock price resumed its strong rally this week after the company achieved...
What's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
Zacks via Yahoo Finance· 6 days agoThe following day, i.e., on Apr 26, AbbVie ABBV is slated to release its first-quarter results...
Cigna to offer Humira rivals with $0 copay at specialty pharmacy By Reuters
Investing.com· 4 days agoCigna said it will stock high- and low-concentration biosimilar versions of Humira from drugmakers...